Bleakley Financial Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-426
Closed -$41.9K 1048
2024
Q3
$41.9K Sell
426
-622
-59% -$80.3K ﹤0.01% 1004
2024
Q2
$171K Buy
1,048
+620
+145% +$88.3K ﹤0.01% 911
2024
Q1
$65.2K Buy
+428
New +$71.2K ﹤0.01% 956

Other funds holding AGL

Bleakley Financial Group's AGL Position: Q4 2024 in Review

Bleakley Financial Group sold out of Agilon Health (AGL) in Q4 2024, closing a stake of 426 shares — an estimated $41.9K sold.

Bleakley Financial Group first reported a position in AGL in Q1 2024 and held it in 3 quarters. The position peaked at $171K in Q2 2024. 184 funds tracked by Wall St. Rank hold AGL as of Q4 2024.

  • Bleakley Financial Group reported no remaining Agilon Health position as of Q4 2024 after selling out during the quarter.
  • Bleakley Financial Group sold 426 Agilon Health shares in Q4 2024, an estimated $41.9K.
  • Bleakley Financial Group first reported a position in Agilon Health in Q1 2024 and held it in 3 quarters.
  • Bleakley Financial Group's Agilon Health position peaked at $171K in Q2 2024.
  • 184 funds tracked by Wall St. Rank held Agilon Health as of Q4 2024.

Based on Bleakley Financial Group's 13F filing for Q4 2024, filed 27 Jan 2025.